がん点滴療法の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE1958)
◆英語タイトル:Global Cancer Infusion Therapy Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE1958
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、がん点滴療法の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(薬局、在宅医療機関、その他)、用途別市場規模(がん、慢性疾患、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・がん点滴療法の市場動向
・企業の競争状況、市場シェア
・がん点滴療法の種類別市場規模(薬局、在宅医療機関、その他)
・がん点滴療法の用途別市場規模(がん、慢性疾患、その他)
・がん点滴療法の北米市場規模2016-2027(アメリカ、カナダ)
・がん点滴療法の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・がん点滴療法のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・がん点滴療法の中南米市場規模2016-2027(メキシコ、ブラジル)
・がん点滴療法の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Option Care Health、Coram CVS、UnitedHealth Group、HCA Healthcare、McLaren、CHI Health、Accredo Health、PharMerica)
・結論
【レポートの概要】

Cancer treatments often require infusion treatments, like chemotherapy. 

Market Analysis and Insights: Global Cancer Infusion Therapy Market
The global Cancer Infusion Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Infusion Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Infusion Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Infusion Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Infusion Therapy market.

Global Cancer Infusion Therapy Scope and Market Size
Cancer Infusion Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Pharmacies
Home Health Agencies
Others

Segment by Application
Cancer
Chronic Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Infusion Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacies
1.2.3 Home Health Agencies
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Infusion Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Chronic Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cancer Infusion Therapy Market Perspective (2016-2027)
2.2 Cancer Infusion Therapy Growth Trends by Regions
2.2.1 Cancer Infusion Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Infusion Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Infusion Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Infusion Therapy Industry Dynamic
2.3.1 Cancer Infusion Therapy Market Trends
2.3.2 Cancer Infusion Therapy Market Drivers
2.3.3 Cancer Infusion Therapy Market Challenges
2.3.4 Cancer Infusion Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cancer Infusion Therapy Players by Revenue
3.1.1 Global Top Cancer Infusion Therapy Players by Revenue (2016-2021)
3.1.2 Global Cancer Infusion Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Infusion Therapy Revenue
3.4 Global Cancer Infusion Therapy Market Concentration Ratio
3.4.1 Global Cancer Infusion Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Infusion Therapy Revenue in 2020
3.5 Cancer Infusion Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Infusion Therapy Product Solution and Service
3.7 Date of Enter into Cancer Infusion Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Infusion Therapy Breakdown Data by Type
4.1 Global Cancer Infusion Therapy Historic Market Size by Type (2016-2021)
4.2 Global Cancer Infusion Therapy Forecasted Market Size by Type (2022-2027)

5 Cancer Infusion Therapy Breakdown Data by Application
5.1 Global Cancer Infusion Therapy Historic Market Size by Application (2016-2021)
5.2 Global Cancer Infusion Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cancer Infusion Therapy Market Size (2016-2027)
6.2 North America Cancer Infusion Therapy Market Size by Type
6.2.1 North America Cancer Infusion Therapy Market Size by Type (2016-2021)
6.2.2 North America Cancer Infusion Therapy Market Size by Type (2022-2027)
6.2.3 North America Cancer Infusion Therapy Market Size by Type (2016-2027)
6.3 North America Cancer Infusion Therapy Market Size by Application
6.3.1 North America Cancer Infusion Therapy Market Size by Application (2016-2021)
6.3.2 North America Cancer Infusion Therapy Market Size by Application (2022-2027)
6.3.3 North America Cancer Infusion Therapy Market Size by Application (2016-2027)
6.4 North America Cancer Infusion Therapy Market Size by Country
6.4.1 North America Cancer Infusion Therapy Market Size by Country (2016-2021)
6.4.2 North America Cancer Infusion Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Cancer Infusion Therapy Market Size (2016-2027)
7.2 Europe Cancer Infusion Therapy Market Size by Type
7.2.1 Europe Cancer Infusion Therapy Market Size by Type (2016-2021)
7.2.2 Europe Cancer Infusion Therapy Market Size by Type (2022-2027)
7.2.3 Europe Cancer Infusion Therapy Market Size by Type (2016-2027)
7.3 Europe Cancer Infusion Therapy Market Size by Application
7.3.1 Europe Cancer Infusion Therapy Market Size by Application (2016-2021)
7.3.2 Europe Cancer Infusion Therapy Market Size by Application (2022-2027)
7.3.3 Europe Cancer Infusion Therapy Market Size by Application (2016-2027)
7.4 Europe Cancer Infusion Therapy Market Size by Country
7.4.1 Europe Cancer Infusion Therapy Market Size by Country (2016-2021)
7.4.2 Europe Cancer Infusion Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cancer Infusion Therapy Market Size (2016-2027)
8.2 Asia-Pacific Cancer Infusion Therapy Market Size by Type
8.2.1 Asia-Pacific Cancer Infusion Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Infusion Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Infusion Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Infusion Therapy Market Size by Application
8.3.1 Asia-Pacific Cancer Infusion Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Infusion Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Infusion Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Infusion Therapy Market Size by Region
8.4.1 Asia-Pacific Cancer Infusion Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Infusion Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cancer Infusion Therapy Market Size (2016-2027)
9.2 Latin America Cancer Infusion Therapy Market Size by Type
9.2.1 Latin America Cancer Infusion Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Infusion Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Infusion Therapy Market Size by Type (2016-2027)
9.3 Latin America Cancer Infusion Therapy Market Size by Application
9.3.1 Latin America Cancer Infusion Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Infusion Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Infusion Therapy Market Size by Application (2016-2027)
9.4 Latin America Cancer Infusion Therapy Market Size by Country
9.4.1 Latin America Cancer Infusion Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Infusion Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cancer Infusion Therapy Market Size (2016-2027)
10.2 Middle East & Africa Cancer Infusion Therapy Market Size by Type
10.2.1 Middle East & Africa Cancer Infusion Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Infusion Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Infusion Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Infusion Therapy Market Size by Application
10.3.1 Middle East & Africa Cancer Infusion Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Infusion Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Infusion Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Infusion Therapy Market Size by Country
10.4.1 Middle East & Africa Cancer Infusion Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Infusion Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Option Care Health
11.1.1 Option Care Health Company Details
11.1.2 Option Care Health Business Overview
11.1.3 Option Care Health Cancer Infusion Therapy Introduction
11.1.4 Option Care Health Revenue in Cancer Infusion Therapy Business (2016-2021)
11.1.5 Option Care Health Recent Development
11.2 Coram CVS
11.2.1 Coram CVS Company Details
11.2.2 Coram CVS Business Overview
11.2.3 Coram CVS Cancer Infusion Therapy Introduction
11.2.4 Coram CVS Revenue in Cancer Infusion Therapy Business (2016-2021)
11.2.5 Coram CVS Recent Development
11.3 UnitedHealth Group
11.3.1 UnitedHealth Group Company Details
11.3.2 UnitedHealth Group Business Overview
11.3.3 UnitedHealth Group Cancer Infusion Therapy Introduction
11.3.4 UnitedHealth Group Revenue in Cancer Infusion Therapy Business (2016-2021)
11.3.5 UnitedHealth Group Recent Development
11.4 HCA Healthcare
11.4.1 HCA Healthcare Company Details
11.4.2 HCA Healthcare Business Overview
11.4.3 HCA Healthcare Cancer Infusion Therapy Introduction
11.4.4 HCA Healthcare Revenue in Cancer Infusion Therapy Business (2016-2021)
11.4.5 HCA Healthcare Recent Development
11.5 McLaren
11.5.1 McLaren Company Details
11.5.2 McLaren Business Overview
11.5.3 McLaren Cancer Infusion Therapy Introduction
11.5.4 McLaren Revenue in Cancer Infusion Therapy Business (2016-2021)
11.5.5 McLaren Recent Development
11.6 CHI Health
11.6.1 CHI Health Company Details
11.6.2 CHI Health Business Overview
11.6.3 CHI Health Cancer Infusion Therapy Introduction
11.6.4 CHI Health Revenue in Cancer Infusion Therapy Business (2016-2021)
11.6.5 CHI Health Recent Development
11.7 Accredo Health
11.7.1 Accredo Health Company Details
11.7.2 Accredo Health Business Overview
11.7.3 Accredo Health Cancer Infusion Therapy Introduction
11.7.4 Accredo Health Revenue in Cancer Infusion Therapy Business (2016-2021)
11.7.5 Accredo Health Recent Development
11.8 PharMerica
11.8.1 PharMerica Company Details
11.8.2 PharMerica Business Overview
11.8.3 PharMerica Cancer Infusion Therapy Introduction
11.8.4 PharMerica Revenue in Cancer Infusion Therapy Business (2016-2021)
11.8.5 PharMerica Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ がん点滴療法の世界市場規模・現状・予測2021年-2027年(Global Cancer Infusion Therapy Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。